determined by the outcome of the two TQT (the regulatory company gold typical for assessment of QT prolongation) domperidone does not appear to be strongly related to QT prolongation at oral doses of twenty mg QID in balanced volunteers. even further, there are minimal case reviews supporting an association with cardiac dysfunction, and also the of